Change Theme
Business Line
Sun, Sep 15, 2024
USFDA cites manufacturing lapses at Zydus Lifesciences' Jarod plant
USFDA sought a detailed remediation plan from the drug firm with timelines to address the findings of the contamination hazards risk assessment.